Evidence map›Paper›PMID 17855751›Full record

ArticleThe Journal of physiology2007

GABA transient sets the susceptibility of mIPSCs to modulation by benzodiazepine receptor agonists in rat hippocampal neurons.

Jerzy W Mozrzymas, Tomasz Wójtowicz, Michal Piast, Katarzyna Lebida, Paulina Wyrembek, Katarzyna Mercik

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Φ value analysis underscores strong functional and structural compactness of the GABAProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. αACS chemical neuroscience · 2021
    Article
  8. Midazolam: an essential palliative care drug.Palliative care and social practice · 2020
    Review
  9. Review
  10. GABAFrontiers in cellular neuroscience · 2020
    Article
  11. Article
  12. Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  13. Influence of GABAAR monoliganded states on GABAergic responses.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  14. Article
  15. Is attentional blink a byproduct of neocortical attractors?Frontiers in computational neuroscience · 2011
    Article
  16. Article
  17. Article
  18. Slow GABA transient and receptor desensitization shape synaptic responses evoked by hippocampal neurogliaform cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jerzy W MozrzymasLaboratory of Neuroscience, Department of Biophysics, Wrocław Medical University, Chałubiñskiego 3, 50-368 Wroclaw, Poland.
Tomasz Wójtowicz
Michal Piast
Katarzyna Lebida
Paulina Wyrembek
Katarzyna Mercik
Wroclaw Medical University · PL

Funding

Wellcome Trust 070231Wellcome Trust 070231/z/03/z
6 · The paper itself

Abstract

Benzodiazepines (BDZs) are known to increase the amplitude and duration of IPSCs. Moreover, at low [GABA], BDZs strongly enhance GABAergic currents suggesting the up-regulation of agonist binding while their action on gating remains a matter of debate. In the present study we have examined the impact of flurazepam and zolpidem on mIPSCs by investigating their effects on GABA(A)R binding and gating and by considering dynamic conditions of synaptic receptor activation. Flurazepam and zolpidem enhanced the amplitude and prolonged decay of mIPSCs. Both compounds strongly enhanced responses to low [GABA] but, surprisingly, decreased the currents evoked by saturating or half-saturating [GABA]. Analysis of current responses to ultrafast GABA applications indicated that these compounds enhanced binding and desensitization of GABA(A) receptors. Flurazepam and zolpidem markedly prolonged deactivation of responses to low [GABA] but had almost no effect on deactivation at saturating or half-saturating [GABA]. Moreover, at low [GABA], flurazepam enhanced desensitization-deactivation coupling but zolpidem did not. Recordings of responses to half-saturating [GABA] applications revealed that appropriate timing of agonist exposure was sufficient to reproduce either a decrease or enhancement of currents by flurazepam or zolpidem. Recordings of currents mediated by recombinant ('synaptic') alpha1beta2gamma2 receptors reproduced all major findings observed for neuronal GABA(A)Rs. We conclude that an extremely brief agonist transient renders IPSCs particularly sensitive to the up-regulation of agonist binding by BDZs.

Indexed as

GABA-A Receptor AgonistsAnimalsCells, CulturedElectrophysiologyFlurazepamGABA Modulatorsgamma-Aminobutyric AcidHippocampusInhibitory Postsynaptic PotentialsPatch-Clamp TechniquesPyridinesRatsRats, WistarReceptors, NeurotransmitterSynaptic TransmissionZolpidemFlurazepamGABA-A Receptor AgonistsGABA Modulatorsgamma-Aminobutyric AcidPyridinesReceptors, NeurotransmitterZolpidem

Identifiers

PMID17855751
PMCPMC2375456
OpenAlexW1496861555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.